அரச சமூகம் சந்தித்தல் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Transgene to Present Its Immuno-Oncology Expertise at Upcoming Scientific Conferences
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that
members of Transgene s management and scientific team have been invited to participate at upcoming (virtual) scientific conferences:
ESMO Targeted Anticancer Therapies Congress 2021 which will take place March 2-4:
Éric Quéméneur, Executive Vice President and Chief Scientific Officer (CSO), will be speaking in the session Where next with Oncolytics
about
Date Time: March 3
rd at 4.20pm (CET)
Royal Society Meeting on Immuno-oncology: How to get the immune system to beat cancer which will take place March 24-25: ....

Lucie Larguier , Transgene Euronext , Kaidre Bendjama , Sylvie Berrebi , Citigate Dewe Rogerson , Royal Society , Royal Society Meeting On , Anticancer Therapies Congress , Corporate Communications , Regulatory News , Euronext Paris , Executive Vice President , Chief Scientific Officer , Oncolytics About Antibody , Society Meeting , Annual European Neoantigen Summit , Project Leader , Personalized Cancer Vaccines , Artificial Intelligence , Risk Factors , Universal Registration Document , அரச சமூகம் , அரச சமூகம் சந்தித்தல் ஆன் , பெருநிறுவன தகவல்தொடர்புகள் , ஒழுங்குமுறை செய்தி , நிர்வாகி துணை ப்ரெஸிடெஂட் ,